Results 101 to 110 of about 5,206,853 (166)

Production, Purification and Characterization of the Hen Egg- White Lysozyme Inhibitor from Enterobacter cloacae M-1002

open access: yes, 2013
Three hen egg-white lysozyme inhibitor producing strains, Enterobacter cloacae M-1002, E. sakazakii M-1204, and Erwinia rhapontici H-55, were isolated from the soils of Taiwan. E. cloacae M-1002 appeared to be a promising inhibitor producing strain.
王三郎; Wang, S. L.; 白其昇; Pai, C. S.; 謝順堂; Shieh, S. T.   +1 more
core   +1 more source

Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes

open access: yes, 2013
OBJECTIVES: The intrinsically encoded ramA gene has been linked to tigecycline resistance through the up-regulation of efflux pump AcrAB in Enterobacter cloacae. The molecular basis for increased ramA expression in E.
De Majumdar, Shyamasree   +4 more
core   +1 more source

Draft Genome Sequence of a High-Level Colistin-Resistant Clinical Strain of the Enterobacter cloacae Complex

open access: yes, 2017
Strain WCHECl-C4 of the Enterobacter cloacae complex, recovered from the blood of a patient with peritonitis, was high-level resistant to colistin.
Zhiyong Zong   +3 more
core   +1 more source

Draft Genome Sequences of Two Enterobacter cloacae subsp. cloacae Strains Isolated from Australian Hematology Patients with Bacteremia

open access: yes, 2017
Enterobacter cloacae is a common member of the gut microbiota in healthy individuals. However, it is also an opportunistic pathogen, capable of causing bacteremia. We report the draft genomes of two Enterobacter cloacae
David Shaw   +5 more
core   +1 more source

Cluster analysis and genetic characterization of enterobacter cloacae complex from blood cultures [PDF]

open access: yes, 2019
Background: Enterobacter cloacae bacteremia is reported as an important cause of morbidity and mortality. The members of E. cloacae complex are clinically involved in nosocomial infections.
Majidpour, A.   +3 more
core  

Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections

open access: yesAntimicrobial Agents and Chemotherapy
Thirty-day mortality was similar in a propensity-score-weighted cohort of 73 patients with KPC-producing Enterobacterales infections treated with ceftazidime-avibactam or meropenem-vaborbactam.
Sara M. Karaba   +9 more
doaj   +1 more source

Emerg Infect Dis

open access: yes
We characterized a collection of IMI-like-producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1-producing sequence type 820 E. cloacae subspecies cloacae that was involved in an outbreak.

core  

Isolation and characterization of bacteriophages for carbapenem resistant Enterobacter cloacae complex strains. [PDF]

open access: yesSci Rep
Imanaka M   +11 more
europepmc   +1 more source

Correction: Ambler class C-type β-lactamases and porin alterations in Enterobacter cloacae complex and Klebsiella aerogenes in the Netherlands, 2012-2023. [PDF]

open access: yesBMC Microbiol
van Gorp E   +14 more
europepmc   +1 more source

Ambler class C-type β-lactamases and porin alterations in Enterobacter cloacae complex and Klebsiella aerogenes in the Netherlands, 2012-2023. [PDF]

open access: yesBMC Microbiol
van Gorp E   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy